NasdaqCM - Nasdaq Real Time Price USD
Catalyst Pharmaceuticals, Inc. (CPRX)
22.70
-0.76
(-3.24%)
As of 1:01:02 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 0.5 | 0.49 | 1.94 | 2.2 |
| Low Estimate | 0.39 | 0.34 | 1.3 | 1.18 |
| High Estimate | 0.61 | 0.62 | 2.37 | 2.62 |
| Year Ago EPS | 0.56 | 0.57 | 2.21 | 1.94 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 140.53M | 139.52M | 557.23M | 606.82M |
| Low Estimate | 133.81M | 134.82M | 550.7M | 558.13M |
| High Estimate | 147.23M | 141.93M | 565.58M | 663.5M |
| Year Ago Sales | 122.71M | 128.69M | 491.73M | 557.23M |
| Sales Growth (year/est) | 14.53% | 8.41% | 13.32% | 8.90% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.43 | 0.51 | 0.55 | 0.53 |
| EPS Actual | 0.56 | 0.57 | 0.7 | 0.68 |
| Difference | 0.13 | 0.06 | 0.15 | 0.15 |
| Surprise % | 31.45% | 12.71% | 28.36% | 29.11% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.5 | 0.49 | 1.94 | 2.2 |
| 7 Days Ago | 0.54 | 0.54 | 2.16 | 2.52 |
| 30 Days Ago | 0.55 | 0.54 | 2.18 | 2.49 |
| 60 Days Ago | 0.52 | 0.5 | 1.94 | 2.03 |
| 90 Days Ago | 0.52 | 0.5 | 1.97 | 2.03 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CPRX | -10.14% | -13.40% | -12.09% | 13.10% |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 3/3/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/27/2025 |
| Initiated | Baird: Outperform | 2/4/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | B of A Securities: Buy to Buy | 1/9/2025 |
Related Tickers
CORT Corcept Therapeutics Incorporated
71.58
+1.59%
ADMA ADMA Biologics, Inc.
21.52
-8.87%
HALO Halozyme Therapeutics, Inc.
68.42
-2.45%
EXEL Exelixis, Inc.
36.76
-0.14%
HRMY Harmony Biosciences Holdings, Inc.
33.68
+0.71%
ACAD ACADIA Pharmaceuticals Inc.
16.96
+14.48%
AXSM Axsome Therapeutics, Inc.
110.07
-0.71%
RIGL Rigel Pharmaceuticals, Inc.
18.85
+2.07%
TGTX TG Therapeutics, Inc.
35.02
+0.48%
RARE Ultragenyx Pharmaceutical Inc.
36.58
+9.46%